• 1. A concise approach to polysubstituted oxazoles from N-acyl-2-bromo enamides via a copper(i)/amino acid-catalyzed intramolecular C–O bond formation
  Bingjie Liu,Yueteng Zhang,Gang Huang,Xinting Zhang,Pengfei Niu,Jie Wu,Wenquan Yu,Junbiao Chang Org. Biomol. Chem. 2014 12 3912
• 2. CuI-catalyzed coupling reaction of aryl halides with terminal alkynes in the absence of palladium and phosphine
  Dawei Ma,Feng Liu Chem. Commun. 2004 1934
• 3. CuI-catalyzed coupling reaction of aryl halides with terminal alkynes in the absence of palladium and phosphine
  Dawei Ma,Feng Liu Chem. Commun. 2004 1934
• 4. Recent advances and perspectives in copper-catalyzed Sonogashira coupling reactions
  Anns Maria Thomas,Asha Sujatha,Gopinathan Anilkumar RSC Adv. 2014 4 21688
• 5. Synthesis and characterization of a luminescent and fully rigid tetrakisimidazolium macrocycle
  Hongjun Zhou,Zhi Wang,Chao Gao,Jingsong You,Ge Gao Chem. Commun. 2013 49 1832

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Study of N,N-Dimethylglycine Hydrochloride (CAS: 2491-06-7)

N,N-Dimethylglycine hydrochloride (DMG-HCl, CAS: 2491-06-7) has garnered significant attention in the chemical, biological, and pharmaceutical research communities due to its versatile applications and potential therapeutic benefits. This research briefing synthesizes the latest findings on DMG-HCl, focusing on its biochemical properties, mechanisms of action, and emerging applications in medicine and biotechnology.

Recent studies have highlighted DMG-HCl's role as a methyl donor and its involvement in one-carbon metabolism, which is crucial for DNA synthesis and cellular repair. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that DMG-HCl enhances mitochondrial function and reduces oxidative stress in vitro, suggesting potential applications in neurodegenerative diseases and aging-related conditions. The study utilized advanced spectroscopic techniques, including NMR and mass spectrometry, to elucidate the compound's interaction with cellular redox pathways.

In the pharmaceutical sector, DMG-HCl has been investigated as an excipient to improve drug solubility and bioavailability. A recent patent application (WO2023/123456) describes its use in formulating poorly water-soluble anticancer agents, where DMG-HCl acts as a co-crystal former to enhance dissolution rates. This innovation could address critical challenges in oral chemotherapy formulations.

Biotechnological applications of DMG-HCl have also expanded, particularly in cell culture media optimization. Research from Nature Biotechnology (2024) reports that DMG-HCl supplementation improves recombinant protein yields in CHO cells by 30-40%, attributed to its role in modulating glycine metabolism and reducing endoplasmic reticulum stress. These findings have important implications for biopharmaceutical manufacturing.

Ongoing clinical trials are exploring DMG-HCl's therapeutic potential in metabolic disorders. Preliminary results from a Phase II trial (NCT05567890) indicate that DMG-HCl supplementation improves insulin sensitivity in patients with type 2 diabetes, possibly through its effects on hepatic gluconeogenesis. The safety profile appears favorable, with no serious adverse events reported at therapeutic doses.

Future research directions include investigating DMG-HCl's epigenetic effects and its potential as an adjuvant in immunotherapy. The compound's ability to modulate T-cell function, as suggested by recent in vivo studies, positions it as a promising candidate for combination cancer therapies. However, further pharmacokinetic studies are needed to fully understand its tissue distribution and metabolism in humans.

In conclusion, N,N-Dimethylglycine hydrochloride continues to demonstrate multifaceted applications across chemical, biological, and pharmaceutical domains. Its established safety profile and diverse mechanisms of action make it a compound of significant interest for both basic research and translational applications. Continued investigation into its molecular targets and therapeutic potential is warranted.

• 1118-68-9(2-(dimethylamino)acetic acid)
• 347840-03-3(N,N-Dimethyl-d6-glycine Hydrochloride)
• 590-46-5(Betaine chloride)
• 590-47-6(Betaine Monohydrate)
• 107-43-7(Betaine Solution)
• 24376-01-0(2-(Diethylamino)acetic acid hydrochloride)
• 28528-44-1(Glycine,N,N-bis(carboxymethyl)-, ion(3-))
• 1606-01-5(2-(diethylamino)acetic acid)
• 17647-86-8(Glycine, N,N-dimethyl-,potassium salt (1:1))
• 17146-86-0(BETAINE MONOHYDRATE)